Table 1.
Study and participant characteristics.
Characteristics | N | % | |
---|---|---|---|
Participant characteristics | Minority group* | ||
Black or African American | 1716 | 17.6 | |
Hispanic or Latinx | 6556 | 67.2 | |
Asian | 1154 | 11.8 | |
American Indian or Alaska Native | 97 | 1.0 | |
Sexual and Gender Minority | 173 | 1.8 | |
Not specified/“Other” minority races | 53 | 0.5 | |
Study characteristics | Minority group | ||
Black or African American | 4 | 44.4 | |
Hispanic or Latinx | 2 | 22.2 | |
Asian | 3 | 33.3 | |
American Indian or Alaska Native | 1 | 11.1 | |
Sexual and Gender Minority | 2 | 22.2 | |
Not specified/”Other” minority races | 1 | 11.1 | |
Genders enrolled | |||
Female only | 7 | 77.8 | |
Male only | 1 | 11.1 | |
Female and male | 1 | 11.1 | |
Intervention participants | |||
Adolescents/young adults only | 5 | 55.6 | |
Parents of Minors | 1 | 11.1 | |
Parents and Minors | 3 | 33.3 | |
Vaccination status at enrollment | |||
Unvaccinated | 6 | 66.7 | |
Received first dose of series | 2 | 22.2 | |
Any number of doses, incomplete series | 1 | 11.1 | |
Publication year | |||
2015-2016 | 6 | 66.7 | |
2017-2018 | 3 | 33.3 | |
Study design | |||
RCT | 8 | 88.9 | |
Non-randomized | 1 | 11.1 | |
Sample size | |||
<100 | 2 | 22.2 | |
100-500 | 6 | 66.7 | |
500-1000 | 0 | 0 | |
>1000 | 1 | 11.1 |
*Minority groups are defined here using race and ethnicity classifications of the U.S. Census Bureau [22]. Sexual and gender minority populations include, but are not limited to, individuals who identify as lesbian, gay, bisexual, asexual, transgender, two-spirit, queer, and/or intersex, as defined by the National Institutes of Health Sexual and Gender Minority Research Office [23].